Prefilled Syringes Market Size, Share, Trends and Analysis

According to Stratistics MRC, the Global Prefilled Syringes market is accounted for $4.45 billion in 2015 and is expected to reach $11.18 billion by 2022 growing at a CAGR of 14.0% during the forecast period. Rising prevalence of chronic diseases, technological advancements and rising number of biologics are the key factors fueling the market growth. On the other hand, stringent government regulations and high cost of these syringes are hampering the market.
Rising combination therapy is one of the major trends that can be seen in the prefilled syringes. The growing number of self-injection patients and technological advancements is creating new growth opportunities for the players in the prefilled syringes market. North America leads the market owing to increasing demand from the home-based healthcare treatment. Glass-based prefilled syringes commanded the largest market in terms of both volume and revenue owing to the ideal characteristics of the material.

Browse full report with TOC@

Some of the key players in the market include Nipro Corporation, West Pharmaceutical Services, Inc., Bespak, Unilife Corporation, Gerresheimer AG, Vetter Pharma International GmbH, Becton, Dickinson & Company, Ypsomed Holding AG, Baxter International Inc., Stevanato Group and Schott AG.

Therapeutic Application Covered:
Hormonal disorders
Auto-immune diseases
Other Therapeutic Applications

Usage Type Covered:
Specialty prefilled syringes
Conventional prefilled syringes
Safety prefilled syringes

Barrel Type Covered:
Dual chambered
Customized prefilled syringes
Single chambered

Product Type Covered:
Plastic-based Prefilled Syringes
Glass-based Prefilled Syringes
What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic...